Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Nov 24, 2015
Insider Transaction Report
Form 4
Farrell Geraldine T
VP Operations, General Counsel
Transactions
- Exercise/Conversion
Options to purchase shares
2015-11-23−4,300→ 5,733 total(indirect: By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>)Exercise: $0.13Exp: 2019-07-01→ Ordinary Shares (4,300 underlying) - Exercise/Conversion
Ordinary Shares
2015-11-23$0.13/sh+4,300$538→ 21,253 total(indirect: By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>)
Holdings
- 4,300
Ordinary Shares
- 132(indirect: By Nexvet EBT Limited)
Ordinary Shares
Footnotes (3)
- [F1]The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities.
- [F2]The reporting person has sole voting and dispositive power over the reported securities pursuant to that certain Nominee Deed dated as of 11/14/14 by and between Nexvet EBT Limited and the persons named in the schedule thereto. Such Nominee Deed was executed in connection with the Issuer's November 2014 four-for-five share consolidation.
- [F3]4,300 options to purchase shares vested and became exercisable on 11/19/15 after the Issuer's board of directors determined that there had been successful completion of an efficacy trial for an Issuer product. A further 2,867 options shall vest and become exercisable on 7/1/16, and 2,866 will vest on 7/1/17.